ACM
ABBV icon

Advent Capital Management’s AbbVie ABBV Stock Holding History

Advent Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Hold
15,000
– – 0.09% 140
2025
Q4 		$3.43M Buy
+15,000
New +$3.42M 0.07% 157
2025
Q1 		– Sell
-18,000
Closed -$3.2M – 211
2024
Q4 		$3.2M Buy
+18,000
New +$3.31M 0.07% 128
2024
Q3 		– Sell
-30,000
Closed -$5.15M – 226
2024
Q2 		$5.15M Buy
30,000
+10,000
+50% +$1.66M 0.12% 107
2024
Q1 		$3.64M Sell
20,000
-10,000
-33% -$1.72M 0.09% 110
2023
Q4 		$4.65M Buy
30,000
+10,000
+50% +$1.46M 0.11% 122
2023
Q3 		$2.98M Hold
20,000
– – 0.07% 149
2023
Q2 		$2.69M Hold
20,000
– – 0.05% 172
2023
Q1 		$3.19M Buy
20,000
+5,000
+33% +$764K 0.06% 154
2022
Q4 		$2.42M Buy
+15,000
New +$2.3M 0.04% 189
2022
Q2 		– Sell
-37,000
Closed -$6M – 248
2022
Q1 		$6M Sell
37,000
-3,000
-8% -$436K 0.1% 163
2021
Q4 		$5.42M Hold
40,000
– – 0.09% 158
2021
Q3 		$4.32M Buy
40,000
+10,000
+33% +$1.14M 0.08% 150
2021
Q2 		$3.38M Hold
30,000
– – 0.07% 160
2021
Q1 		$3.25M Buy
+30,000
New +$3.21M 0.07% 142
2020
Q4 		– Sell
-40,000
Closed -$3.5M – 201
2020
Q3 		$3.5M Buy
40,000
+5,000
+14% +$471K 0.08% 132
2020
Q2 		$3.44M Buy
+35,000
New +$3.08M 0.08% 128
2018
Q2 		– Sell
-6,000
Closed -$568K – 278
2018
Q1 		$568K Sell
6,000
-33,243
-85% -$3.65M 0.01% 210
2017
Q4 		$3.79M Buy
39,243
+34,243
+685% +$3.23M 0.07% 151
2017
Q3 		$444K Buy
+5,000
New +$381K 0.01% 201
2015
Q4 		– Sell
-22,274
Closed -$1.21M – 466
2015
Q3 		$1.21M Sell
22,274
-4,926
-18% -$321K 0.02% 354
2015
Q2 		$1.83M Buy
27,200
+13,700
+101% +$894K 0.03% 350
2015
Q1 		$790K Buy
+13,500
New +$816K 0.01% 379

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advent Capital Management's ABBV Position: Q1 2026 in Review

Advent Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 15,000 shares worth $3.26M. The position accounts for 0.09% of the portfolio, ranked #140.

Advent Capital Management first reported a position in ABBV in Q1 2015 and has held it in 23 quarters since. The position peaked at $6M in Q1 2022. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Advent Capital Management held 15,000 shares of AbbVie worth $3.26M as of Q1 2026.
  • Advent Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.09% of Advent Capital Management's portfolio in Q1 2026, its #140 holding.
  • Advent Capital Management first reported a position in AbbVie in Q1 2015 and has held it in 23 quarters since.
  • Advent Capital Management's AbbVie position peaked at $6M in Q1 2022.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Advent Capital Management's 13F filing for Q1 2026, filed 7 May 2026.